This record was last updated May 15, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to assess whether Shengbai Oral Formula is a viable option for treatment of fatigue, pain, and neutropenia in patients undergoing their third cycle of chemotherapy.
Protocol Amendment History
4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-11-25; most recent amendment 2025-05-13.
Status change: Not Yet Recruiting → Recruiting2025-01-27